Brain, Vol. 113, No. 6, 1823-1842, 1990
© 1990 Guarantors of Brain
research-article |
STRIATONIGRAL DEGENERATION
A CLINICOPATHOLOGICAL STUDY
National Hospital for Nervous Diseases, Queen Square London, UK
Correspondence to:
Correspondence to: Dr A. J. Lees, National Hospital for Nervous Diseases, Queen Square, London WCIN 3BG, UK.
The clinical and pathological features of 10 cases of striatonigral degeneration are described: 5 were misdiagnosed in life as Parkinson's disease. Retrospectively, helpful early pointers to the diagnosis in these cases included unexplained falls, autonomic dysfunction, absence of rest tremor and failure to respond to L-dopa, but these were not always present. The pathological diagnosis could not be excluded on macroscopic examination of the striatum. Relative preservation of the putamen occurred in the 4 patients who benefited from L-dopa. The caudate nucleus was involved in all cases and there was no sparing of the large striatal neurons. In mild cases, involvement of the putamen was confined to its posterior two-thirds, dorsolaterally. With increasing severity this extended in a dorsal to ventral and posterior to anterior direction. Seven of the cases had evidence of olivopontocerebellar damage, but only 2 of these had clinical evidence of cerebellar disease. Correlation was found between the neuronal counts in caudate: putamen, striatum:nigra compacta, globus pallidus:nigra compacta, nigra compacta:locus coeruleus. The most severely involved part of the substantia nigra pars compacta was the ventrolateral zone, which projects to the dorsal putamen, the earliest site of striatal disease.
Received October 4, 1989. Revised December 14, 1989. Accepted December 21, 1989.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. S. O'Sullivan, L. A. Massey, D. R. Williams, L. Silveira-Moriyama, P. A. Kempster, J. L. Holton, T. Revesz, and A. J. Lees Clinical outcomes of progressive supranuclear palsy and multiple system atrophy Brain, May 1, 2008; 131(5): 1362 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Lyoo, Y. Jeong, Y. H. Ryu, S. Y. Lee, T. J. Song, J. H. Lee, J. O. Rinne, and M. S. Lee Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy Brain, February 1, 2008; 131(2): 438 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Murase and R. D. McKay A specific survival response in dopamine neurons at most risk in Parkinson's disease. J. Neurosci., September 20, 2006; 26(38): 9750 - 9760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Grubb Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance Circulation, June 7, 2005; 111(22): 2997 - 3006. [Full Text] [PDF]
|
|
|
|
|
|
T. Ozawa, D. Paviour, N. P. Quinn, K. A. Josephs, H. Sangha, L. Kilford, D. G. Healy, N. W. Wood, A. J. Lees, J. L. Holton, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations Brain, December 1, 2004; 127(12): 2657 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-S. Lu, Y.-H. Weng, M.-C. Chen, R.-S. Chen, K.-Y. Tzen, S.-P. Wey, G. Ting, H.-C. Chang, and T.-C. Yen 99mTc-TRODAT-1 Imaging of Multiple System Atrophy J. Nucl. Med., January 1, 2004; 45(1): 49 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Osaki, Y. Ben-Shlomo, G.K. Wenning, S.E. Daniel, A. Hughes, A.J. Lees, C.J. Mathias, and N. Quinn Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology, November 26, 2002; 59(10): 1486 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Ghaemi, R Hilker, J Rudolf, J Sobesky, and W-D Heiss Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging J. Neurol. Neurosurg. Psychiatry, November 1, 2002; 73(5): 517 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kraft, C. Trenkwalder, and D. P. Auer T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease Neurology, October 22, 2002; 59(8): 1265 - 1267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K A Jellinger Neuropathological findings in multiple system atrophy with dystonia J. Neurol. Neurosurg. Psychiatry, October 1, 2002; 73(4): 460 - 461. [Full Text] [PDF]
|
|
|
|
|
|
S M Boesch, G K Wenning, G Ransmayr, and W Poewe Dystonia in multiple system atrophy J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(3): 300 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.F.H. Schocke, K. Seppi, R. Esterhammer, C. Kremser, W. Jaschke, W. Poewe, and G. K. Wenning Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD Neurology, February 26, 2002; 58(4): 575 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J Burn and E Jaros Multiple system atrophy: cellular and molecular pathology Mol. Pathol., December 1, 2001; 54(6): 419 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Soliveri, D. Monza, D. Paridi, F. Carella, S. Genitrini, D. Testa, and F. Girotti Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy J. Neurol. Neurosurg. Psychiatry, September 1, 2000; 69(3): 313 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G K Wenning, Y Ben-Shlomo, A Hughes, S E Daniel, A Lees, and N P Quinn What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J. Neurol. Neurosurg. Psychiatry, April 1, 2000; 68(4): 434 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kraft, J. Schwarz, C. Trenkwalder, T. Vogl, T. Pfluger, and W. H. Oertel The Combination of Hypointense and Hyperintense Signal Changes on T2-Weighted Magnetic Resonance Imaging Sequences: A Specific Marker of Multiple System Atrophy? Arch Neurol, February 1, 1999; 56(2): 225 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Caraceni, M. Savoiardo, M. Grisoli, D. Testa, and F. Girotti Multiple System Atrophy Arch Neurol, March 1, 1996; 53(3): 212 - 212. [Abstract] [PDF]
|
|
|
|
|
|
C. Colosimo, A. Albanese, A. J. Hughes, V. M. S. de Bruin, and A. J. Lees Some Specific Clinical Features Differentiate Multiple System Atrophy (Striatonigral Variety) From Parkinson's Disease Arch Neurol, March 1, 1995; 52(3): 294 - 298. [Abstract] [PDF]
|
|
|
|
|
|
D. Perani, S. Bressi, D. Testa, F. Grassi, P. Cortelli, S. Gentrini, M. Savoiardo, T. Caraceni, and F. Fazio Clinical/Metabolic Correlations in Multiple System Atrophy: A Fludeoxyglucose F 18 Positron Emission Tomographic Study Arch Neurol, February 1, 1995; 52(2): 179 - 185. [Abstract] [PDF]
|
|
|
|
 |
|
 R. G. Feldman and A. C. McKee Case 46-1993- A 75-Year-Old Man with Right-Sided Rigidity, Dysarthria, and Abnormal Gait N. Engl. J. Med., November 18, 1993; 329(21): 1560 - 1567. [Full Text]
|
|
|
|
|
|
T. Gasser, J. Schwarz, G. Arnold, C. Trenkwalder, and W. H. Oertel Apomorphine Test for Dopaminergic Responsiveness in Patients With Previously Untreated Parkinson's Disease Arch Neurol, November 1, 1992; 49(11): 1131 - 1134. [Abstract] [PDF]
|
|